These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 6356741)

  • 1. Follow-up of patients with prolactinomas after discontinuation of long-term therapy with bromocriptine.
    Zárate A; Canales ES; Cano C; Pilonieta CJ
    Acta Endocrinol (Copenh); 1983 Oct; 104(2):139-42. PubMed ID: 6356741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persisting suppression of prolactin secretion after long-term treatment with bromocriptine in patients with prolactinomas.
    Eversmann T; Fahlbusch R; Rjosk HK; von Werder K
    Acta Endocrinol (Copenh); 1979 Nov; 92(3):413-27. PubMed ID: 574700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis and drug therapy of prolactinoma.
    Ciccarelli E; Camanni F
    Drugs; 1996 Jun; 51(6):954-65. PubMed ID: 8736617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bromocriptine treatment of seven women with primary amenorrhoea and prolactin-secreting pituitary tumours.
    Bergh T; Nillius SJ; Wide L
    Clin Endocrinol (Oxf); 1979 Feb; 10(2):145-54. PubMed ID: 570900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Five years follow-up of invasive prolactinomas with special reference to the control of cavernous sinus invasion.
    Wu ZB; Su ZP; Wu JS; Zheng WM; Zhuge QC; Zhong M
    Pituitary; 2008; 11(1):63-70. PubMed ID: 17917811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of pregnancy and lactation on pituitary prolactin-secreting tumours.
    Zárate A; Canales ES; Alger M; Forsbach G
    Acta Endocrinol (Copenh); 1979 Nov; 92(3):407-12. PubMed ID: 517046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical, Hormonal, and Neuroradiological Characteristics and Therapeutic Outcomes of Prolactinomas in Children and Adolescents at a Single Center.
    Yang A; Cho SY; Park H; Kim MS; Kong DS; Shin HJ; Jin DK
    Front Endocrinol (Lausanne); 2020; 11():527. PubMed ID: 32849307
    [No Abstract]   [Full Text] [Related]  

  • 8. Rapid regression through bromocriptine therapy of a suprasellar extending prolactinoma during pregnancy.
    Tan SL; Jacobs HS
    Int J Gynaecol Obstet; 1986 Jun; 24(3):209-15. PubMed ID: 2880760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolactinomas in infertile women: clinical and endocrine characteristics before and after 24 months of treatment with bromocriptine.
    Hajder M; Hajder E; Dervisefendic M; Samardzic R; Alic E
    Med Arch; 2013; 67(3):181-4. PubMed ID: 23848038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conservative management of pituitary prolactinomas; evidence for bromocriptine-induced regression.
    Hancock KW; Scott JS; Lamb JT; Gibson RM; Chapman C
    Br J Obstet Gynaecol; 1980 Jun; 87(6):523-9. PubMed ID: 7397087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bromocriptine treatment of women with suspected pituitary prolactin-secreting microadenomas.
    Archer DF; Lattanzi DR; Moore EE; Harger JH; Herbert DL
    Am J Obstet Gynecol; 1982 Jul; 143(6):620-5. PubMed ID: 7201244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary medical therapy of micro- and macroprolactinomas in men.
    Pinzone JJ; Katznelson L; Danila DC; Pauler DK; Miller CS; Klibanski A
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3053-7. PubMed ID: 10999785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypogonadism, galactorrhoea and hyper-prolactinaemia: Evaluation of pituitary gonadotrophins reserve before and under bromocriptine.
    Asfour M; L'Hermite M; Hedouin-Quincampoix M; Fossati P
    Acta Endocrinol (Copenh); 1977 Apr; 84(4):738-49. PubMed ID: 322432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term follow-up of women with amenorrhea-galactorrhea treated with bromocriptine.
    Tartagni M; Nicastri PL; Diaferia A; Di Gesù I; Loizzi P
    Clin Exp Obstet Gynecol; 1995; 22(4):301-6. PubMed ID: 8777784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Withdrawal of bromocriptine after long-term therapy for macroprolactinomas; effect on plasma prolactin and tumour size.
    van 't Verlaat JW; Croughs RJ
    Clin Endocrinol (Oxf); 1991 Mar; 34(3):175-8. PubMed ID: 2036725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The long-term effects of megavoltage radiotherapy as sole or combined therapy for large prolactinomas: studies with high definition computerized tomography.
    Johnston DG; Hall K; Kendall-Taylor P; Ross WM; Crombie AL; Cook DB; Watson MJ
    Clin Endocrinol (Oxf); 1986 Jun; 24(6):675-85. PubMed ID: 3098457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of bromocriptine-induced pregnancy on prolactin-secreting pituitary tumours.
    Bergh T; Nillius SJ; Larsson SG; Wide L
    Acta Endocrinol (Copenh); 1981 Nov; 98(3):333-8. PubMed ID: 7293665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bromocriptine treatment of hyperprolactinemia].
    Gauer J; Heberling HJ; Stubert B; Richardt W; Lohmann D
    Z Gesamte Inn Med; 1985 Jul; 40(13):393-6. PubMed ID: 4036221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of therapy and pregnancy on hyperprolactemia caused by a pituitary adenoma. A clinical case].
    Pasinetti E; Schivardi MR; Falsetti L; Gastaldi A
    Minerva Ginecol; 1989 Mar; 41(3):157-60. PubMed ID: 2666885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discordant responses of prolactinoma to two different dopamine agonists.
    Ahmed SR; Shalet SM
    Clin Endocrinol (Oxf); 1986 Apr; 24(4):421-6. PubMed ID: 3742834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.